SNDL Inc.
NASDAQ:SNDLDrug Manufacturers - Specialty & Generic
-$0.03 today
- Market cap
- $326.64M
- Beta
- 0.91
- P/E (TTM)
- -47.4
- EPS (TTM)
- -$0.04
Volume 1.00M
Average 2.21M
SNDL EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
SNDL Inc.NASDAQ: SNDL
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA grows, but more slowly than its trailing trend
Q1 FY2026 EBITDA of CA$2.71M rose 106.7% year over year, behind the +201.3% change in trailing-twelve-month EBITDA. Sequentially, it fell 89.4% from the prior quarter.
Context
- EBITDA amounted to 5.1% of revenue in FY2025, up 0.6 pp from a year earlier.
- EBITDA increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 2 analysts of -CA$14M (-129.2%) for the fiscal year ending Dec 2026, a slowdown from the +216.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- CA$2.71M-89.4% QoQ
- Last fiscal yearDec 2025
- CA$48.02M+216.5% YoY
- LTMMar 2026
- CA$49.42M+201.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +106.7% | -20.1% | -126.8 pp |
| 1 year | +216.5% | -129.2% | -345.7 pp |
| 3-year CAGR | — | +6.1% | — |
| 5-year CAGR | +15.1% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
CAD · from the income statement
- Latest · FY2025
- 48.02M CAD
- Year-over-year change
- +216.5%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 48.02M | +216.5% |
| FY2024 | 2024-12-31 | (41.2M) | +58.4% |
| FY2023 | 2023-12-31 | (99.15M) | +69.6% |
| FY2022 | 2022-12-31 | (326.55M) | -45.9% |
| FY2021 | 2021-12-31 | (223.76M) | — |
EBITDA vs competitors
How SNDL compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +201.3% is the 2nd highest of 11, against a peer median of -18.4%.
- EBITDA amounts to 5.3% of revenue for SNDL, versus a peer median of 9.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $154.5M USD | +28.1% | +148.3% | 22.8% | |
| LTM Mar 2026 | CA$49.42M CAD | +201.3% | — | 5.3% | |
| LTM Mar 2026 | $39.9M USD | +145.1% | — | 9.5% | |
| LTM Mar 2026 | $37.31M USD | +1061.2% | +22.4% | 7.3% | |
| LTM Mar 2026 | $27.5M USD | -56.2% | -11.5% | 29.3% | |
| LTM Mar 2026 | -$5.76M USD | -220.1% | +92.3% | 2.5% | |
| LTM Mar 2026 | -$14.03M USD | +53.2% | — | 4.6% | |
| LTM Mar 2026 | -$42.27M USD | -2.3% | — | — | |
| LTM Mar 2026 | -$51.63M USD | -40.6% | — | 102.7% | |
| LTM Mar 2026 | -$176.6M USD | -34.4% | — | — | |
| LTM Mar 2026 | -$184.67M USD | -43.8% | — | — | |
| Peer median (excluding SNDL) | — | -18.4% | +57.3% | 9.5% | |
Competitors are the stored peer set for SNDL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 56.13M | 712.2M | 909.01M | 920.45M | 946.4M |
| Cost of Revenue | 65.13M | 571.82M | 718.59M | 680.12M | 687.75M |
| Gross Profit | (9M) | 140.38M | 190.42M | 240.33M | 258.65M |
| Gross Margin | -16.0% | 19.7% | 20.9% | 26.1% | 27.3% |
| Research & Development | 2.45M | 2.45M | 324K | 346K | 489K |
| Selling, General & Admin | 55.39M | 158.26M | 230.17M | 219.28M | 210.63M |
| Operating Expenses | 125.38M | 488.15M | 353.59M | 344.14M | 263.07M |
| Depreciation & Amortization | 10.16M | 47.32M | 64.95M | 56.71M | 56.27M |
| EBITDA | (223.76M) | (326.55M) | (99.15M) | (41.2M) | 48.02M |
| EBITDA Margin | -398.7% | -45.9% | -10.9% | -4.5% | 5.1% |
| Operating Income | (134.38M) | (347.77M) | (163.17M) | (103.81M) | (4.42M) |
| Operating Margin | -239.4% | -48.8% | -18.0% | -11.3% | -0.5% |
| Interest Income | 13.72M | 17.62M | 15.37M | 16.4M | 8.05M |
| Interest Expense | 776K | 5.9M | 7.92M | 7.7M | 7.52M |
| Other Income / Expenses | (100.32M) | (32M) | (8.85M) | (1.8M) | (11.35M) |
| Income Before Tax | (234.7M) | (379.77M) | (172.02M) | (105.61M) | (15.77M) |
| Pre-Tax Margin | -418.1% | -53.3% | -18.9% | -11.5% | -1.7% |
| Income Tax Expense | (7.91M) | (7.34M) | 0 | (9.41M) | 0 |
| Net Income | (226.98M) | (335.11M) | (172.66M) | (94.8M) | (15.77M) |
| Net Margin | -404.4% | -47.1% | -19.0% | -10.3% | -1.7% |
| EPS (Basic) | (1.24) | (1.50) | (0.65) | (0.38) | (0.06) |
| EPS (Diluted) | (1.24) | (1.50) | (0.65) | (0.38) | (0.06) |
| Weighted Avg Shares | 186.04M | 229.87M | 259.37M | 264.2M | 258.05M |
| Weighted Avg Shares (Diluted) | 186.04M | 229.87M | 259.37M | 264.2M | 258.05M |
SNDL Inc.
NASDAQ:SNDL
Intrinsic Alpha fair value
Locked
Current Price
$1.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.